Vaxart, Inc. (VXRT)Stock Declines in After-Hours. Here’s Why?
Vaxart, Inc. (Nasdaq: VXRT) recently revealed plans for a public offering of its common stock, coinciding with a decline in its stock price. Additionally, the company provided updates on the progress of its norovirus vaccine development, which may impact investor sentiment. Stock Decline and Public Offering Announcement Vaxart’s stock price experienced a decline, with the […]